Skip to main content
. 2021 Oct 22;11:756096. doi: 10.3389/fonc.2021.756096

Figure 3.

Figure 3

The gene signature predicts worse survival of patients in the training set. (A) Distribution of LASSO coefficients of the E2F-related gene signature. (B) Association between gene signature and the E2F transcription factor family. (C) GSEA validated E2F pathway enrichment in the high-ERS group. (D) ERS was significantly increased in patients who died during follow-up. (E) The patients in the high-ERS group had worse survival. (F) Kaplan-Meier analysis showed a worse OS of patients with higher ERS. (G) tROC analysis showed ERS to be an accurate variable for survival prediction.